1. Home
  2. TALO vs SUPN Comparison

TALO vs SUPN Comparison

Compare TALO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talos Energy Inc.

TALO

Talos Energy Inc.

N/A

Current Price

$15.01

Market Cap

2.7B

Sector

Energy

ML Signal

N/A

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$28.74

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TALO
SUPN
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
TALO
SUPN
Price
$15.01
$28.74
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$21.33
★ $54.14
AVG Volume (30 Days)
★ 2.7M
2.7M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 8100.00
EPS
N/A
★ 2.78
Revenue
★ $1,780,070,000.00
$1,239,000,000.00
Revenue This Year
$31.44
$82.81
Revenue Next Year
$1.94
$8.07
P/E Ratio
★ N/A
$10.20
Revenue Growth
N/A
★ 4.29
52 Week Low
$10.33
$25.92
52 Week High
$18.76
$59.68

Technical Indicators

Market Signals
Indicator
TALO
SUPN
Relative Strength Index (RSI) 37.97 30.73
Support Level $13.96 $25.92
Resistance Level $15.96 $30.18
Average True Range (ATR) 0.74 1.57
MACD -0.07 0.10
Stochastic Oscillator 32.80 46.32

Price Performance

Historical Comparison
TALO
SUPN

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: